APPENDICES - NIHR Health Technology Assessment Programme

DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37
132. Moseley H, Ibbotson S, Woods J, Brancaleon
L, Lesar A, Goodman C, et al. Clinical and
research applications of photodynamic therapy
in dermatology: experience of the Scottish PDT
Centre. Lasers Surg Med 2006;38:403–16.
133. Nagano T, Yamada Y, Ikeda T, Kamo T, Nishioka
E, Nishigori C. [Successful treatment of superficial
cutaneous malignant neoplasms with photodynamic
therapy (PDT) using light-emitting diode (LED)
light source.] Skin Research 2005;4:188–93.
134. Naidenov N, Dencheva R, Tsankov N. Recurrence
rate of basal cell carcinoma after topical
aminolevulinic acid-based photodynamic therapy.
Acta Dermatovenerol Croat 2004;12:157–61.
135. Nikkels AF, Pierard-Franchimont C, Nikkels-
Tassoudji N, Bourguignon R, Pierard GE.
Photodynamic therapy and imiquimod
immunotherapy for basal cell carcinomas. Acta Clin
Belg 2005;60:227–34.
136. Nikkels AF, Thirion L, Quatresooz P, Pierard GE.
Photodynamic therapy for cutaneous verrucous
carcinoma. J Am Acad Dermatol 2007;57:516–19.
137. Oakford M, Keohane SG. Photodynamic therapy to
manage residual superficial basal cell carcinomas
following Mohs’ surgery. Br J Dermatol 2004;151:96.
138. O’Connell M, Walker M, Scott D, Layton AM. A
combined photodynamic therapy, imiquimod,
curettage and cautery approach in the treatment of
large recalcitrant basal cell carcinomas. Br J Dermatol
2007;157:P-104.
139. Orenstein A, Haik J, Tamir J, Winkler E, Trau
H, Malik Z, et al. Photodynamic therapy of
cutaneous lymphoma using 5-aminolevulinic acid
topical application. Dermatol Surg 2000;26:765–9;
discussion 9–70.
140. Orenstein A, Kostenich G, Goldan O, Weisman
O, Winkler E, Haik J, et al. Clinical experience in
controlled photodynamic therapy of skin lesions using
topical 5-aminolevulinic acid. Photodynamic Therapy
and Photodiagnosis in Clinical Practice, Brixen/
Bressanone, 7–11 October 2008. Session 9–2.
141. Orenstein A, Kostenich G, Roitman L, Tsur H,
Katanick D, Kopolovic J, et al. Photodynamic
therapy of malignant lesions of the skin mediated
by topical application of 5-aminolevulinic acid in
combination with DMSO and EDTA. Laser Life Sci
1996;7:49–57.
142. Orenstein A, Kostenich G, Tsur H, Roitman L.
Photodynamic therapy of human skin tumors
using topical application of 5-aminolevulinic
acid, dimethylsulfoxide (DMSO), and edetic acid
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
disodium salt (EDTA). SPIE Proceedings Series
1994;2325:100–5.
143. Oseroff AR, Blumenson LR, Wilson BD, Mang TS,
Bellnier DA, Parsons JC, et al. A dose ranging study
of photodynamic therapy with porfimer sodium
(Photofrin) for treatment of basal cell carcinoma.
Lasers Surg Med 2006;38:417–26.
144. Oseroff AR, Shieh S, Frawley NP, Cheney R,
Blumenson LE, Pivnick EK, et al. Treatment of
diffuse basal cell carcinomas and basaloid follicular
hamartomas in nevoid basal cell carcinoma
syndrome by wide-area 5-aminolevulinic acid
photodynamic therapy. Arch Dermatol 2005;141:60–
7.
145. Paech V, Lorenzen T, Stoehr A, Lange K, Merz H,
Meigel WN, et al. Remission of a cutaneous Mycosis
fungoides after topical 5-ALA sensitisation and
photodynamic therapy in a patient with advanced
HIV-infection. Eur J Med Res 2002;7:477–9.
146. Panjehpour M, Julius CE, Hartman DL, Dougherty
TJ. Photodynamic therapy for skin cancer. SPIE
Proceedings Series 1996;2675:29–31.
147. Pennington DG, Waner M, Knox A. Photodynamic
therapy for multiple skin cancers. Plast Reconstr Surg
1988;82:1067–71.
148. Peris K, Surrenti T, Bianchi L, Papoutsaki M. MAL-
PDT in the treatment of basal cell carcinoma. J Am
Acad Dermatol 2005;52:P161.
149. Perrett CM, Tan SK, Cerio R, Goldsmith PC,
McGregor JM, Proby CM, et al. Treatment of basal
cell carcinoma with topical methylaminolaevulinate
photodynamic therapy in an organ-transplant
recipient. Clin Exp Dermatol 2006;31:146–7.
150. Peter S, Witold Z, Peter H, Alexander B.
Comparison between mALA- and ALA-PDT in the
treatment of basal cell carcinomas. SPIE Proceedings
Series 2006;6139:279–86.
151. Philipp CM, Muller U, Urban P, Berlien HP.
Potential of systemic photosensitizers for PDT
of skin malignancies. SPIE Proceedings Series
2008;6991:19.
152. Pinzi C, Campolmi P, Moretti S, Guasti A, Rossi R,
Cappugi P. [Photodynamic therapy of primary and
secondary (non-melanoma) skin tumors with topical
delta-aminolevulinic acid.] G Ital Dermatol Venereol
2000;135:427–31.
153. Polak-Pacholczyk I, Lassota-Falczewska M,
Bartkowiak R, Kaszuba A. [Photodynamic therapy
of the precancerous states and non-melanoma
skin cancers using the methyl-derivative of
145